help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrine Reviews, doi:10.1210/er.2006-0031
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wullaert, A.
Right arrow Articles by Beyaert, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wullaert, A.
Right arrow Articles by Beyaert, R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Endocrine Reviews 28 (4): 365-386
Copyright © 2007 by The Endocrine Society

Hepatic Tumor Necrosis Factor Signaling and Nuclear Factor-{kappa}B: Effects on Liver Homeostasis and Beyond

Andy Wullaert, Geert van Loo, Karen Heyninck and Rudi Beyaert

Unit of Molecular Signal Transduction in Inflammation, Department for Molecular Biomedical Research-VIB, and Department of Molecular Biology, Ghent University, Technologiepark 927, B-9052 Ghent (Zwijnaarde), Belgium

Correspondence: Address all correspondence and requests for reprints to: Rudi Beyaert, Department for Molecular Biomedical Research, VIB, Ghent University, Technologiepark 927, B-9052 Ghent (Zwijnaarde), Belgium. E-mail: rudi.beyaert{at}dmbr.ugent.be

The proinflammatory cytokine TNF has a pivotal role in liver pathophysiology because it holds the capacity to induce both hepatocyte cell death and hepatocyte proliferation. This dual effect of TNF on hepatocytes reflects its ability to induce both nuclear factor {kappa}B (NF-{kappa}B)-dependent gene expression and cell death. Multiple studies have demonstrated the crucial role of the transcription factor NF-{kappa}B in the decision between life and death of a hepatocyte. Massive hepatocyte apoptosis preceding embryonic lethality in NF-{kappa}B-deficient mice constituted the first indication of an essential antiapoptotic function of NF-{kappa}B in the liver. Although many studies confirmed this crucial cytoprotective role of NF-{kappa}B in adult liver, a number of genetic studies recently obtained conflicting results on the exact role of NF-{kappa}B in different mouse models of TNF hepatotoxicity, demonstrating that caution should be taken when interpreting studies using different NF-{kappa}B-deficient mice in distinct models of liver injury. Recent reports showing a role for hepatic NF-{kappa}B activation in the proliferation of malignant cells during hepatocarcinogenesis, and in the progression of fatty liver diseases to insulin resistance and type 2 diabetes mellitus demonstrate that NF-{kappa}B can also have more detrimental effects in the liver. Moreover, its role in the development of the metabolic syndrome emphasizes that hepatic NF-{kappa}B activation might also have adverse effects on the endocrine system. Therefore, understanding the regulation of hepatic TNF signaling and NF-{kappa}B activation is of critical therapeutic importance. In this review, we summarize how studies on the role of NF-{kappa}B in different mouse models of liver pathologies have contributed to this understanding.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H.-Y. Liu, S. Y. Cao, T. Hong, J. Han, Z. Liu, and W. Cao
Insulin Is a Stronger Inducer of Insulin Resistance than Hyperglycemia in Mice with Type 1 Diabetes Mellitus (T1DM)
J. Biol. Chem., October 2, 2009; 284(40): 27090 - 27100.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Zou, K. M. Beggs, E. M. Sparkenbaugh, A. D. Jones, H. S. Younis, R. A. Roth, and P. E. Ganey
Sulindac Metabolism and Synergy with Tumor Necrosis Factor-{alpha} in a Drug-Inflammation Interaction Model of Idiosyncratic Liver Injury
J. Pharmacol. Exp. Ther., October 1, 2009; 331(1): 114 - 121.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H.-Y. Liu, T. Hong, G.-B. Wen, J. Han, D. Zuo, Z. Liu, and W. Cao
Increased basal level of Akt-dependent insulin signaling may be responsible for the development of insulin resistance
Am J Physiol Endocrinol Metab, October 1, 2009; 297(4): E898 - E906.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. E.-M. Peychal, A. Bilger, H. C. Pitot, and N. R. Drinkwater
Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17
Carcinogenesis, May 1, 2009; 30(5): 879 - 885.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Haimerl, A. Erhardt, G. Sass, and G. Tiegs
Down-regulation of the De-ubiquitinating Enzyme Ubiquitin-specific Protease 2 Contributes to Tumor Necrosis Factor-{alpha}-induced Hepatocyte Survival
J. Biol. Chem., January 2, 2009; 284(1): 495 - 504.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. D. Harrison-Findik, E. Klein, J. Evans, and J. Gollan
Regulation of liver hepcidin expression by alcohol in vivo does not involve Kupffer cell activation or TNF-{alpha} signaling
Am J Physiol Gastrointest Liver Physiol, January 1, 2009; 296(1): G112 - G118.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. D. Buzzelli, M. Nagarajan, J. F. Radtka, M. L. Shumate, M. Navaratnarajah, C. H. Lang, and R. N. Cooney
Nuclear Factor-{kappa}B Mediates the Inhibitory Effects of Tumor Necrosis Factor-{alpha} on Growth Hormone-Inducible Gene Expression in Liver
Endocrinology, December 1, 2008; 149(12): 6378 - 6388.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Matsushima-Nishiwaki, S. Takai, S. Adachi, C. Minamitani, E. Yasuda, T. Noda, K. Kato, H. Toyoda, Y. Kaneoka, A. Yamaguchi, et al.
Phosphorylated Heat Shock Protein 27 Represses Growth of Hepatocellular Carcinoma via Inhibition of Extracellular Signal-regulated Kinase
J. Biol. Chem., July 4, 2008; 283(27): 18852 - 18860.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. L. Moss, S. Gross, S. T. Gammon, A. Vinjamoori, and D. Piwnica-Worms
Identification of a Ligand-induced Transient Refractory Period in Nuclear Factor-{kappa}B Signaling
J. Biol. Chem., March 28, 2008; 283(13): 8687 - 8698.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. Goel, B. Boylan, L. Gruman, P. J. Newman, P. E. North, and D. K. Newman
The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis
Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1205 - G1214.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. Faulkner, D. M. Altmann, S. Ellmerich, I. Huhtaniemi, G. Stamp, and S. Sriskandan
Sexual Dimorphism in Superantigen Shock Involves Elevated TNF-{alpha} and TNF-{alpha} induced Hepatic Apoptosis
Am. J. Respir. Crit. Care Med., September 1, 2007; 176(5): 473 - 482.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society